DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
D-Tryptophan is an investigational drug.
There have been 16 clinical trials for D-Tryptophan. The most recent clinical trial was a Phase 1 trial, which was initiated on December 10th 2020.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), NewLink Genetics Corporation, and H. Lee Moffitt Cancer Center and Research Institute.
Recent Clinical Trials for D-Tryptophan
|Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery||Advanced Accelerator Applications||Phase 1|
|Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery||Stanford University||Phase 1|
|Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study||National Cancer Institute (NCI)||Phase 3|